Mahamaya Lifesciences
add_icon

Mahamaya Lifesciences

140.95
-2.05
(-1.43%)
Market Cap
329.90 Cr
PE Ratio
25.86
Volume
20,400.00
Day High - Low
143.00 - 136.80
52W High-Low
205.05 - 111.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
329.90 Cr
EPS
7.60
PE Ratio
25.86
PB Ratio
2.94
Book Value
48.58
EBITDA
26.00
Dividend Yield
0.00 %
Industry
Chemicals
Return on Equity
26.19
Debt to Equity
1.52
Forecast For
Actual

Company News

View All News
Caret
neutral
Mahamaya Lifesciences reschedules deployment of Rs. 3449.03 lakhs unutilised IPO proceeds to March 2028, citing technical execution factors for manufacturing plant projects.
neutral
Mahamaya Lifesciences Limited has withdrawn from the Arihant Capital Bharat Connect Virtual Conference Rising Star 2026 due to internal scheduling constraints and business priorities.
positive
Mahamaya Lifesciences Limited received the prestigious 'Company of the Year – Medium Scale' award at ICSCE 2026 in Dubai, organized by PMFAI on January 20, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
625.55
#1 52,753.80
25.79
#1 47,123.00
8.13
820
-42.56
41.48
2,909.50
44,142.39
30.24
8,322.00
5.70
#1 1,660
-16.47
36.98
4,717.50
21,201.43
29.93
5,593.10
7.89
568
179.82
59.18
387.00
19,316.94
36.09
3,268.60
11.19
506
-13.27
41.46
978.60
8,828.98
15.32
4,379.40
#1 35.89
304
#1 366.56
40.05
238.65
4,641.00
31.33
2,631.40
6.54
164
-274.07
35.37
962.10
4,336.99
#1 14.79
2,071.30
15.49
297
27.97
35.97
137.99
3,229.15
-69.87
1,242.60
-30.48
-92
71.82
56.13
180.43
2,339.62
178.63
449.80
9.63
14
27.78
29.89
1,275.80
2,120.52
15.96
1,199.00
12.53
141
-1.23
26.90
Growth Rate
Revenue Growth
64.13 %
Net Income Growth
148.08 %
Cash Flow Change
102.29 %
ROE
23.77 %
ROCE
11.19 %
EBITDA Margin (Avg.)
9.09 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Revenue
0
120
Expenses
0
108
EBITDA
0
12
Operating Profit %
0 %
8 %
Depreciation
0
1
Interest
0
3
Profit Before Tax
0
7
Tax
0
2
Net Profit
0
6
EPS in ₹
0.00
3.11

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
56
78
112
188
Fixed Assets
20
21
22
27
Current Assets
33
54
87
157
Capital Work in Progress
2
2
3
4
Investments
0
0
0
0
Other Assets
34
54
88
157
Total Equity & Liabilities
56
78
112
188
Current Liabilities
30
48
78
132
Non Current Liabilities
10
11
9
7
Total Equity
16
19
25
49
Reserve & Surplus
15
18
23
32
Share Capital
1
1
1
18

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
1
-0
1
Investing Activities
-3
-3
-2
-8
Operating Activities
2
1
-23
1
Financing Activities
1
2
24
9

Share Holding

% Holding
Feb 2025
Oct 2025
Nov 2025
Promoter
77.27 %
77.27 %
56.35 %
FIIs
0.00 %
0.00 %
6.39 %
DIIs
0.00 %
0.00 %
4.67 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
12.72 %
Others
22.73 %
22.73 %
19.88 %
No of Share Holders
18
18
1,034

Technical Indicators

RSI(14)
Neutral
33.77
ATR(14)
Less Volatile
7.46
STOCH(9,6)
Oversold
12.06
STOCH RSI(14)
Oversold
3.17
MACD(12,26)
Bearish
-2.37
ADX(14)
Strong Trend
27.33
UO(9)
Bearish
34.63
ROC(12)
Downtrend And Accelerating
-8.36
WillR(14)
Oversold
-89.50